Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technology. by Pêssoa, Rodrigo et al.
Molecular Characterization of Human T-Cell
Lymphotropic Virus Type 1 Full and Partial Genomes by
Illumina Massively Parallel Sequencing Technology
Rodrigo Pessoˆa1, Jaqueline Tomoko Watanabe1, Youko Nukui2, Juliana Pereira2, Jorge Kasseb3,
Augusto Ce´sar Penalva de Oliveira3, Aluisio Cotrim Segurado4, Sabri Saeed Sanabani5*
1Department of Virology, Sa˜o Paulo Institute of Tropical Medicine, Sa˜o Paulo, Brazil, 2Department of Hematology, Faculty of Medicine, University of Sa˜o Paulo, Sa˜o Paulo,
Brazil, 3Department of Neurology, Institute of Infectology Emilio Ribas, Sa˜o Paulo, Brazil, 4Department of Infectious Diseases, Faculty of Medicine, University of Sa˜o Paulo,
Sa˜o Paulo, Brazil, 5Clinical Laboratory, Department of Pathology, Hospital das Clı´nicas, School of Medicine, University of Sa˜o Paulo, Sa˜o Paulo, Brazil
Abstract
Background: Here, we report on the partial and full-length genomic (FLG) variability of HTLV-1 sequences from 90 well-
characterized subjects, including 48 HTLV-1 asymptomatic carriers (ACs), 35 HTLV-1-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) and 7 adult T-cell leukemia/lymphoma (ATLL) patients, using an Illumina paired-end protocol.
Methods: Blood samples were collected from 90 individuals, and DNA was extracted from the PBMCs to measure the
proviral load and to amplify the HTLV-1 FLG from two overlapping fragments. The amplified PCR products were subjected
to deep sequencing. The sequencing data were assembled, aligned, and mapped against the HTLV-1 genome with
sufficient genetic resemblance and utilized for further phylogenetic analysis.
Results: A high-throughput sequencing-by-synthesis instrument was used to obtain an average of 3210- and 5200-fold
coverage of the partial (n = 14) and FLG (n = 76) data from the HTLV-1 strains, respectively. The results based on the
phylogenetic trees of consensus sequences from partial and FLGs revealed that 86 (95.5%) individuals were infected with
the transcontinental sub-subtypes of the cosmopolitan subtype (aA) and that 4 individuals (4.5%) were infected with the
Japanese sub-subtypes (aB). A comparison of the nucleotide and amino acids of the FLG between the three clinical settings
yielded no correlation between the sequenced genotype and clinical outcomes. The evolutionary relationships among the
HTLV sequences were inferred from nucleotide sequence, and the results are consistent with the hypothesis that there were
multiple introductions of the transcontinental subtype in Brazil.
Conclusions: This study has increased the number of subtype aA full-length genomes from 8 to 81 and HTLV-1 aB from 2 to
5 sequences. The overall data confirmed that the cosmopolitan transcontinental sub-subtypes were the most prevalent in
the Brazilian population. It is hoped that this valuable genomic data will add to our current understanding of the
evolutionary history of this medically important virus.
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Introduction
Human T-cell leukemia virus type I (HTLV-1) is the retrovirus
responsible for adult T-cell leukemia/lymphoma (ATLL) and for
the chronic neurological disorder HTLV-1-associated myelopa-
thy/tropical spastic paraparesis (HAM/TSP) [1,2,3,4]. The virus
has also been implicated in a variety of inflammatory diseases,
such as uveitis [5], pulmonary alveolitis [6], Hashimoto thyroiditis
[7], and chronic arthropathy [8]. Globally, an estimated 10–20
million individuals are HTLV-1 carriers [9]. The disease burden is
unevenly distributed in endemic areas, particularly in southwest
Japan, the Caribbean islands, South America, and portions of
Central Africa [10,11]. Among the 15 to 25 million HTLV-1-
infected individuals living throughout the world, approximately 1
to 5% will develop ATL or HAM/TSP, depending on as-yet-
unknown cofactors that could vary according to geographical
location [12].
Similar to other retroviruses, HTLV-1 carries a diploid RNA
genome comprising 9032 nucleotides that is reverse-transcribed
into double-stranded DNA that integrates into the host genome as
a provirus [13]. This genome contains gag, pol and env genes
flanked by long terminal repeat (LTR) sequences at both the 59
and 39 ends. A distinct molecular structure, known as the pX
region, that is not present in other retroviruses is found between
env and the 39 LTR. The plus strand of the pX region encodes the
regulatory proteins p40 (Tax), p27 (Rex), p12, p13, p30, and p21,
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which are critical to the viral infectivity in resting primary
lymphocytes and to proliferation in infected cells [14].
Much of our current understanding of the HTLV-1 genome
structure, variability and evolution has come from the conven-
tional Sanger di-deoxy sequencing approach applied to viral
partial sequences. According to previously published data on
phylogenetic comparisons of partial sequences, seven subtypes of
HTLV-1 strains have been described thus far (a–g) [15]: the
cosmopolitan subtype A, the Australo-Melanesian subtype C and
the Central African subtype B, D, E, F and G. The cosmopolitan
subtype A is further divided into five sub-subtypes : (A)
Transcontinental, (B) Japanese, (C) West African, (D) North
African, and (E) the Peruvian Black [11,16,17]. However, only 2
HTLV-1 subtypes (a and 1b) have had their whole genomes
sequenced to date. The data on the complete genome sequences of
the HTLV-1 strains found in Brazil are scant. Of note, HTLV-1
infection is endemic in Brazil, and the prevalence varies across
different regions of Brazil [18,19]. Recently, it has been reported
that the overall seroprevalence of HTLV infection among 281,760
first-time donors from three blood centers in Brazil was
approximately 135 per 105 [19]. The same study reported an
incidence of 3.66105 person-years, and the residual transfusion
risk was 5.06106 per blood unit transfused. A high prevalence of
HTLV-1 infection has been reported in Salvador, a large city in
the eastern part of Brazil, with an estimated prevalence of 1.35%
among blood donors and 1.76% of the overall population [20].
The transcontinental sub-subtypes found in Brazil are believed to
have been recently introduced from Africa, most likely through the
post-Columbian migrations of the African slave trade between the
sixteenth and nineteenth centuries[20,21].
DNA sequencing has been dramatically advanced by increas-
ingly high-throughput technology. Recent work has employed this
technology to enable the characterization of entire viral popula-
tions in human and nonhuman primates [22,23,24] and to identify
minor genomic variants [25,26]. It is somewhat surprising then
that despite millions of people being infected with HTLV-1
worldwide, what was known about HTLV-1 strain genomes was
primarily derived from shorter partial sequences of the viral
genomes. The scarcity of HTLV-1 complete genome sequences
prompted us to characterize and generate newer genetic materials
of these viruses, which provide a useful tool for studying viral
origin and evolution, in addition to aiding epidemiological
monitoring. Here, we combined Illumina’s sequencing by
synthesis (SBS) technology with a transposon-based fragmentation
method to perform genome wide ultra-deep sequencing of 90
HTLV-1 amplified genomes. From this data, we sought to
investigate whether different molecular subtypes were associated
with disease development in the participating subjects.
Materials and Methods
Study Population
Ninety participants were randomly selected from a larger cohort
of 233 HTLV-1-infected persons representing 48 (53.3%) asymp-
tomatic carriers (ACs), 35 (38.9%) HAM/TSP patients and 7
(7.8%) ATLL patients. This sub-cohort was part of an ongoing
project to profile human T-cells miRNAs in the course of HTLV-1
infection using a deep-sequencing approach. A decision to include
90 samples was made because up to 96 samples can be pooled and
sequenced together in a single flow cell. HTLV-1-positive
individuals were recruited from the HTLV-1 outpatient clinic at
the University of Sao Paulo and the Institute of Infectious Diseases
‘‘Emilio Ribas.’’ All ACs were diagnosed as HTLV-1 carriers at
the time of blood donation. Viral infection was identified by the
Murex HTLV I + II (Abbott/Murex, Wiesbaden, Germany) and
Vironostika HTLVI/II (bioMe´rieux bv, Boxtel, Netherlands)
HTLV enzyme immunoassays, and infection was confirmed by
HTLV BLOT 2.4 (HTLV blot 2.4, Genelabs Diagnostics, Science
Park, Singapore). The clinical status of HAM/TSP was deter-
mined based on the WHO criteria for HTLV-1-associated diseases
[27]. Diagnostic criteria for ATLL included serologic evidence of
HTLV-1 infection and cytologically or histologically proven T cell
malignancy. Written informed consent was obtained from each
participant. The study was approved by the local review board
(Comissa˜o de E´tica para Ana´lise de Projetos de Pesquisa,
CAPPesq).
DNA extraction and HTLV-1 proviral load determination
DNA was extracted from peripheral blood mononuclear cells
(PBMCs) using a commercial kit (Qiagen GmbH, Hilden
Germany) following the manufacturer’s instructions. The extract-
ed DNA was used as a template to amplify a 97-bp fragment from
the HTLV-1 tax region using previously published primers [28].
The TaqMan real-time PCR assay was conducted in a 25-mL
reaction mixture containing 10 mL of KAPA PROBE FAST
Universal qPCR Master mix kit (KapaBiosystems), 5 mL of
template DNA, 0.4 mM of each primer and 0.2 mM of the final
concentration of each probe. Amplification and analysis were
performed with the Applied Biosystems 7500 real-time PCR
system using an initial denaturation step at 95uC for 2 minutes,
followed by 40 cycles of 95uC for 10 seconds and 57uC for
45 seconds. A fragment of the RNase P gene from humans [29] was
used as an internal control. A negative, no-template control (H2O
control) was run with every assay. Standard curves for HTLV-1 tax
were generated from MT-2 cells of log10 dilutions (from 10
5 to 100
copies). The threshold cycle for each clinical sample was calculated
by defining the point at which the fluorescence exceeded a
threshold limit. Each sample was assayed in duplicate, and the
mean of the two values was considered the copy number of the
sample. The HTLV-1 proviral load was calculated as the copy
number of HTLV-1 (tax) per 1000 cells = (copy number of HTLV-
1 tax)/(copy number of RNase P gene/2)61000 cells. The method
could detect 1 copy per 103 PBMCs.
Amplification of the complete provirus genomes
The complete provirus genome was amplified in two large
fragments (A, 4.939 bp, nt 10 to 4930, and B, 4562 bp, nt 4459 to
9006) from 200–300 ng of extracted genomic DNA. The
structural and regulatory genes of each sequence were mapped
based on comparison with the genomic sequence of B1033-2009
sub-subtype aB from Japan (GenBank accession no. AB513134).
Fragment A was amplified using the primers HTLV-1 FG_O1S
59TGA CAA TGA CCA TGA GCC CCA AAT ATC CCC
CGG93 and HTLV-1 FG_O1R 59GCT GGA GTC GGG GGG
AGT GGT GAA GCT GCC93. Fragment B was amplified using
the primers HTLV-1 FG_O2S 59CGC CGG GGC CTA CTT
CCT AAC CAC ATC TGG CAA GG93 and HTLV-1 FG_O2R
59TCT CCT GAG AGT GCT ATA GGA TGG GCT GTC
GCT GGC TCC TAT93. The boldface nucleotides (non-HTLV-
1 specific sequences) are tails at the 59 end of the outer primers and
were added to enhance the nested amplification with inner
primers. The PCR products were then subjected to nested PCR to
amplify the A and B nested fragments. The nested primers for
fragment A were HTLV-1 FG_N1S 59CCA TGA GCC CCA
AAT ATC CCC CGG93 and HTLV-1 FG_N1R 59GGG GGG
AGT GGT GAA GCT GCC93. The nested primers for fragment
B were HTLV-1 FG_N2S 59GGC CTA CTT CCT AAC CAC
ATC TGG CAA GG93 and HTLV-1 FG_N2R 59GGA GCC
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AGC GAC AGC CCA TCC TAT93. The PCR conditions for
outer and inner PCR were as follows: an initial step of 5 min at
94uC; 35 cycles, with 1 cycle consisting of 30 s at 94uC, 30 s at
60uC, and 5 min at 72uC; and a final step of 10 min at 72uC. The
amplified DNA fragments from the nested PCR product were
separated by gel electrophoresis and purified using Freeze ‘N
Squeeze DNA Gel Extraction Spin Columns. Each purified
amplicon was quantified using Quant-IT HS reagents (Invitrogen,
Life Technologies, Carlsbad, CA), and both amplicons from a
single viral genome were pooled together at equimolar ratios.
Whole viral genome library preparation
Each pool was then quantitated, and approximately 1 ng of
each was used in a fragmentation reaction mix using a Nextera
XT DNA sample prep kit according to the manufacturer’s
protocol. Briefly, tagmentation and fragmentation of each pool
were simultaneously performed by incubation for 5 min at 55uC
followed by incubation in neutralizing tagment buffer for 5 min at
room temperature. After neutralization of the fragmented DNA, a
light 12-cycle PCR was performed with Illumina Ready Mix to
add Illumina flowcell adaptors, indexes and common adapters for
subsequent cluster generation and sequencing. Amplified DNA
was then purified using Agencourt AMPure XP beads (Beckman
Coulter), which excluded very short library fragments. Following
AMPure purification, the quantity of each library was normalized
to ensure equally library representation in our pooled samples.
Prior to cluster generation, normalized libraries were further
quantified by qPCR using the SYBR fast Illumina library
quantification kit (KAPA Biosystems) following the instructions
of the manufacturer. The qPCR was run on the 7500 Fast Real-
Time PCR System (Applied Biosystems). The thermocycling
conditions consisted of an initial denaturation step at 95uC for
5 min followed by 35 cycles of [30 s at 95uC and 45 s at 60uC].
The final libraries were pooled at equimolar concentration and
diluted to 4 nM. To denature the indexed DNA, 5 mL of the 4 nM
library were mixed with 5 mL of 0.2 N fresh NaOH and incubated
for 5 min at room temperature. 990 mL of chilled Illumina HT1
buffer was added to the denatured DNA and mixed to make a
20 pM library. After this step, 360 mL of the 20 pM library was
multiplexed with 6 mL of 12.5 pM denatured PhiX control to
increase sequence diversity and then mixed with 234 mL of chilled
HT1 buffer to make a 12 pM sequenceable library. Finally,
600 mL of the prepared library was loaded on an Illumina MiSeq
clamshell style cartridge for paired end 250 sequencing.
Data analysis
Fastq files were generated by the Illumina MiSeq reporter for
downstream analysis and validated to evaluate the distribution of
quality scores and to ensure that quality scores do not drastically
drop over each read. Validated fastq files from each viral genome
were de novo assembled into contiguous sequences and annotated
with CLC Genomics Workbench version 5.5 (CLC Bio, Aarhus,
Denmark) and the Sequencher program 5.2 (Gene Code Corp.,
Ann Arbor, MI). To improve the quality of reads, approximately
10 nucleotides were trimmed from the 39 end of the reads from
each sequence library of each sample. Because the repetitive and
identical sequences of both LTR presented the biggest difficulty in
assembling HTLV-1 genome sequence data, we decided to only
use the 39 LTR sequence from each sequence for further analysis.
The contiguous genomic sequence from each virus strain was
extracted from the assembly and used for further analysis. The full
designation of samples is 0YYBR_CLNXXX, where 0YY stands
for the year of study, BR for Brazil, CLN for clinical status, and
XXX for the enrolment number.
To increase the reliability of the observed DNA variations, the
background error rate was set at 1% meaning that DNA variations
detected in at least 1% of the viral sequences within a given sample
are genuine variations.
Open reading frames were individually aligned with prototype
variant B1033-2009 using the MAFFT algorithm [30]. Individual
open reading frame alignments were then concatenated, and the
nucleotide-level similarities of the resulting full-length coding
genomes (gag, pol, env p30 and tax) were calculated using MEGA5
[31]. Bayesian inference (BI) phylogenetic analyses were conduct-
ed using MrBayes v. 3.2 [32]. The settings used for the analysis of
the resulting partial and full-length coding genomes were nst = 6,
with the gamma-distributed rate variation across sites and a
proportion of invariable sites (rates = invgamma). Posterior prob-
ability distributions were generated using the Markov Chain
Monte Carlo (MCMC) method with four chains being run
simultaneously for 1,000,000 generations. Burn-in fraction was set
at 2500 and trees were sampled every 100 generations. Due to the
large size of the LTR dataset and the limited computer capacity,
analyses were run until the average standard deviation of split
frequencies fell below 0.05. At termination, parameters and trees
were summarized with a burnin of 25%. The plot of log-likelihood
values over generations were assessed for adequate sampling and
potential scale reduction factors for convergence. All trees were
displayed using either FigTree v1.4 (http://tree.bio.ed.ac.uk/) or
the freely available Archaeopteryx Java software [33]. Nucleotide
similarities were estimated using a maximum composite likelihood
model implemented in MEGA version 5.0 software.
GenBank accession numbers
All consensus genome assemblies generated in this study were
submitted to NCBI’s GenBank database (Accession numbers
KF797891–KF797895, KF797896–KF797912, and KF797896–
KF797912).
Results
In total, 90 blood samples from HTLV-1 infected individuals
were included in the study. The participants’ ages ranged between
31 and 81 years, and the median age was 56 years. Females
constituted 68.9% (n= 62) of the study group. The median
measurements of CD4 and CD8 lymphocyte percentage by flow
cytometry (FACScan, Becton-Dickinson, Cowley, Oxford) were
45% and 22%, respectively, in 31% of subjects. The median
proviral loads defined in this study in all the ACS, HAM/TSP and
ATLL groups were 431 copies per 103 PBMCs (range, 2–420), 177
copies per 103 PBMCs (range, 4–1035) and 273 copies per 103
PBMCs (153–3279), respectively. The mean time to HTLV-1
diagnosis was 8.865.4 years. The characteristics of the 90 patients
included in the study are summarized in Table 1.
PCR amplifications were successful in all samples, even those
harboring proviral copy numbers as low as 2 copies per 103
PBMCs. To assess the genetic variability of HTLV-1, the FLG
sequences were successfully assembled into a single, high-quality
contig in 76 HTLV-1 sequences, with the majority starting
approximately at position 727 of the 59 long terminal repeat (LTR)
to the extreme 39 LTR at position 9113 (average length of
8259 bp). No ambiguities were detected between the two
overlapping sequences, indicating that errors due to PCR had
little effect on the overall sequences of the proviral genome of these
sequences. The read-through translation of the 5 open reading
frames indicated that all complete coding sequences obtained in
this study were intact and in frame. There were several nucleotide
substitutions in the complete coding regions. Among these, we
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found 29 specific nucleotides that were always simultaneously
substituted in 27 participants and were identical to the prototype
Japanese ATK (sub-subtype aB, GenBank accession number
J02029) (Table 2). Almost all of these substitutions were detected
in 13 of 43 asymptomatic carriers, 12 of 31 HAM/TSP patients
and 2 of 6 patients with ATLL. In 10 cases with such nucleotide
substitutions, several other base substitutions were always simul-
taneously observed (Table 2). Close inspection of the BI tree
inferred from the complete coding region alignment indicated that
the viral sequences from these 10 cases clustered closely, forming a
monophyletic lineage that falls into the transcontinental sub-
subtype A cluster (Figure 1, highlighted in yellow). These results
clearly indicate that variations in HTLV-1 are not randomly
distributed but seem to be arranged in hot spots.
The BI tree analysis from the complete coding region
determined that HTLV-1 strains from our patients belonged to
the cosmopolitan transcontinental sub-subtypes or HTLV-1 aA,
except for 3 (4%) samples (012BR ATL003 HC, 012BR ASY032,
and 012BR ATL005 HC), which belonged to the Japanese
HTLV-1 aB sub-subtypes and are represented in this tree by a
single branch (Figure 1). The HTLV-1 aA was detected in all
patients with HAM/TSP, 40 of 41 ASCs, and 4 of 6 patients with
ATLL. No distinctive mutations were observed among the viral
sequences from the three clinical groups. Neither the ASCs nor the
HAM/TSP or ATLL sequences formed a unique cluster. The
maximum nucleotide distances within each group were 0.5%,
0.7% and 0.5% in the TSP/HAM, ATLL and asymptomatic
HTLV-1 infected patients, respectively. The complete genomes of
HTLV-1 aA had a mean nucleotide divergence from HTLV-1 aB
of 1% (Table 3). Based on the latter analysis, it was hard to
determine the relationship between viral sequence and virulence.
Furthermore, HTLV-1 aA had a slightly higher intragroup
divergence than sequences belonging to HTLV-1 aB. The
sequence analysis of the tax gene of the sequences with complete
coding regions confirmed the presence of the complete set of four
polymorphic sites [34] characteristic of tax A in 73 (96%) samples,
but the tax B profile was confirmed in only 3 (4%) strains, namely
012BR ATL003 HC, 012BR ASY032, and 012BR ATL005 HC,
which clustered within the tax B sub-subtypes (Figure 1).
Fourteen HTLV-1 sequences, identified by a phylogenetic tree
from partial data as belonging to the HTLV-1 aA (n= 13) or
HTLV-1 aB (n= 1) sub-subtypes (Figure S1), failed to generate
full genomic data by our deep sequencing method. The de novo
assembly of the compiled genome from each of these sequences
had an average sequencing depth ranging from 351–5713. When
aligned to the B1033-2009 sequence, eight sequences displayed
two contigs separated by a gap of less than 500 bp, suggesting the
small size of most gaps (Figure S1).
Next, the intra-sample single nucleotide variability within each
sample with partial and/or complete coding regions was
investigated for potential quasispecies characterized by nucleotide
substitutions. Based on our rigid criteria, the presence of genuine
DNA variant could not be detected in any of the samples. Hence,
it appeared that no minority viral variants were present in the 90
blood samples analyzed by illumina next generation sequencing.
To further explore the genetic variation and subtype classifica-
tions within the HTLV subtype, all available LTR sequences
(n = 88) were extracted from the HTLV complete and partial
genomes of each subject and aligned with the LTR sequences
representing all assigned subtypes and unassigned variants with a
minimum length of 500 bp from the HTLV-1 molecular
epidemiology database (http://htlv1db.bahia.fiocruz.br/). On
the basis of a phylogenetic analysis of this region (Figure 2), 84
subjects were classified as being infected with subtype aA, and 4
individuals were infected with subtype aB. Moreover, all sequences
classified as subtype aA or aB on the basis of the complete coding
region depicted in Figure 1 displayed a concordant subtype
classification in LTR sub-genomic regions, suggesting the absence
of inter-genomic recombination. As shown in Figure 2, the LTR
sequences from the current study (faint blue branches) were
dispersed among other HTLV-1 aA sequences. Moreover, the
phylogenies of subtype aA displayed no considerable grouping of
sequences by clinical status. To investigate the origin of HTLV-1
subtypes in Brazil, we compiled the LTR data sets of the current
study (n = 88 sequences) and all reference sequences (n = 297
sequences) for these subtypes from different geographic origins,
including Brazil (Figure 3). No significant unique cluster of
Brazilian HTLV-1 aA was observed. Instead, these subtypes are all
interspersed with strains from different geographic locations,
mainly in South America, Europe, Africa and Asia. Seven of the
11 (4 ACs and 3 HAM/TSP) patients of Japanese descent (n = 11)
or those who had sexual contact with a Japanese partner (n = 1) in
this study were infected with HTLV-1 a grouped in a monophy-
letic cluster within the Japanese tax sequences that belong to the
LTR sub-subtypes of cosmopolitan A (Figure 3). This group was
also separated by an excellent aLRT value (93%) in the complete
coding region (Figure 1). In the case of subtype bA (Figure 3),
the 4 LTRs from this study were sequenced from Japanese
descendants and positioned with other Brazilian sequences in a
main cluster of sequences that originated from Japan, Taiwan,
Argentina and Colombia.
Table 1. Demographic and Clinical Characteristics of the
HTLV-1 Patients (n = 90).
Age (years)
Mean 6SD 55.9610.6
Median 56
Range 31–81
Gender (%)
Male 62 (68.9)
Female 28 (31.1)
Clinical status (%)
Asymptomatic carriers (ACs) 48(53.3)
HAM/TSP 35(38.9)
ATLL 7(7.8)
1Median lymphocyte subpopulations
% CD4 cells 45
% CD8 cells 22
2Median proviral load/1000 PBMCs
Asymptomatic carriers 43 (2–420)
HAM/TSP 177 (4–1035)
ATLL 224 (153–3297)
Mean follow-up after HTLV-1 diagnosis (years) 8.865.4
1The median CD4 and CD8 percentage were measured in 31% of subjects
(n = 28).
2Patients with ATLL or HAM/TSP had significantly higher median proviral loads
than ACs (P,0.001), while no significant difference was observed between the
ATLL and HAM/TSP groups P = 0.06 (Mann-Whitney test).
doi:10.1371/journal.pone.0093374.t001
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Discussion
Currently, there are only 15 complete sequences of HTLV-1
sequences in the GenBank and HTLV-1 molecular epidemiology
databases (http://htlv1db.bahia.fiocruz.br/) that were classified as
subtypes aA (n= 8), aB (n= 2), aC (n= 2) and 1b (n= 1) and 2
unassigned, for which some of the sequences have the country of
sampling stated. Among these, there were 3 recovered from Brazil.
The scarcity of these sequences prompted us to generate newer
genetic materials of these viruses and to obtain more information
on the molecular basis of HTLV-1 sequences in Brazil. To date,
no study has employed second-generation sequencing techniques
to examine HTLV-1 heterogeneity across entire genomes from
different clinical settings. In this work, we used state-of-the-art
Illumina MiSeq instrumentation to generate 76 and 14 HTLV-1
complete and partial genome sequences, respectively, from
different ACs, HAM/TSP and ATLL clinical sources in a single
run. Thus, the sequences described in this study quintuple the
publicly available full genome sequence information for HTLV-1
Figure 1. Phylogenetic tree of HTLV-1 sub-subtypes based on Bayesian Inference analysis of the complete coding region sequences
(7593 bp, nucleotide 804–8397 according to position in B1033-2009 ‘‘GenBank accession no. AB513134’’) of 76 participant
samples. Colored (blue, sub-subtype aA; red, sub-subtype aB) and black branches represent patient samples and reference sequences from all
verified sub-subtypes, respectively. Sequences displayed simultaneous base substitutions over the complete coding region (see Table 2) and formed
a monophyletic cluster are indicated by yellow box. For clarity, the tree was midpoint rooted. Values at the nodes represent Bayesian probabilities.
doi:10.1371/journal.pone.0093374.g001
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viruses. Analysis indicates that the vast majority of subjects in this
study was infected with the cosmopolitan genotype, mostly the
transcontinental and more rarely the Japanese sub-subtypes, a
finding that is in agreement with previous reports [35,36,37,38].
Nevertheless, we obtained no evidence that a specific HTLV-1-
subtypes or sub-subtypes are associated with a certain clinical
status. This finding is in accordance with earlier studies
demonstrating that the nucleotide substitutions in some fragments
of the HTLV-1 genome were specific for the geographic origin of
the patients rather than for the type of associated pathologies
[36,39,40,41]. Regardless of the patient’s clinical status, sequence
homogeneity between strains recovered from a common geo-
graphical origin is often seen.
In the present study, 88 Brazilian HTLV-1 LTR sequences
were extracted from their complete genomes and used to
reconstruct the phylogenetic history of the virus in this country.
This region has previously been shown to provide a sufficiently
strong phylogenetic signal to allow the distinction of HTLV-1 sub-
subtypes and contains a larger number of HTLV-1 sequences in
the database [42]. It is important to note that the best resolution of
evolutionary patterns is obtained from complete genomes.
However, this was not possible because there were only a few
HTLV-1 complete genome sequences publicly available. As
expected, all of the transcontinental strains identified in this study
were clustered in different branches with strains from different
geographic origins in Europe, Africa, Asia and, mainly, South
America, corresponding to the formerly named Latin American
cluster. The grouping of the Brazilian HTLV-1 sequences into
different subclusters support the hypothesis that there were
multiple introductions of the transcontinental subtype in Brazil.
These findings further support several studies conducted in some
Brazilian and other Latin American populations that suggested the
introduction of HTLV-1 on multiple occasions and that demon-
strate an association between the Latin American cluster with
sequences of African origin [37,43,44,45,46]. The results of
detecting HTLV-1 aA and aB among patients of Japanese descent
is consistent with previous data described among Japanese
immigrants in Sao Paulo, where the detection of both sub-
subtypes has been reported [17,35,47,48].
In conclusion, we provided new full-length genome sequences of
HTLV-1 from the different clinical setting determined by deep
sequencing for two different variants. Therefore, this study has
increased the number of subtype aA full-length genomes to 81 and
HTLV-1 aB to 5 sequences. Together with other partial
sequences, we confirmed that HTLV-1 subtype a transcontinental
Table 3. Comparison of the nucleotides of the
transcontinental (A) and Japanese (B) sub-subtypes of the
cosmopolitan genotype*.
Intragroup (%) Intergroup (%)
HTLV-1aA HTLV-1aB HTLV-1aA vs HTLV-1aB
Complete genome 0.5 0.2 1.0
gag 0.3 0.2 0.8
polymerase 0.4 0.3 0.8
envelope 0.5 0.2 1.1
pX 0.9 0.2 1.7
*The intra- and intergroup comparisons were performed with the new
sequences generated in this study.
doi:10.1371/journal.pone.0093374.t003
Figure 2. Phylogenetic tree of HTLV-1 sub-subtypes based on Bayesian Inference analysis from the long terminal repeat (LTR,
664 bp) of 88 participant samples and 279 HTLV-1 LTR sequences from the database representing 5 of the HTLV-1 subtypes. The
representatives of the 5 references are color-coded. Branches with posterior probabilities $0.70 are displayed with blank square.
doi:10.1371/journal.pone.0093374.g002
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sub-subtypes A was the most prevalent in the Brazilian population.
We believe that these data open avenues for further studies on the
evolutionary relationships between the HTLV-1 subtypes and may
contribute to the information on the genetic diversity of HTLV-1
worldwide.
Supporting Information
Figure S1 Schematic representation of the sequences
that failed to generate full genomic data when subjected
to our deep sequencing method. Consensus sequence reads
were aligned and mapped to the Brazilian reference sequence
(GenBank: AY563953.1) to define their genomic locations. The
star symbol indicates proviral load (number of proviral copies per
1000 cells). The pilcrow symbol indicates the overall mean
coverage depth.
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